Research graph
References from Modern Cancer Diagnostics in the Era of Precision Oncology: From Liquid Biopsy and Molecular Biomarkers to Artificial Intelligence and Multi-Omics Approaches. A Scoping Review. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2026
2026 · External reference
Breast cancer: Presentation, investigation and management
10.12968/hmed.2021.0459 · 2022 · External reference
Triple-negative breast cancer: Epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
10.1016/j.bcp.2023.115545 · 2023 · External reference
Prostate cancer epidemiology
10.2741/1891 · 2006 · External reference
Epidemiology of liver metastases
10.1016/j.canep.2020.101760 · 2020 · External reference
Updates on global epidemiology, risk and prognostic factors of gastric cancer
10.3748/wjg.v29.i16.2452 · 2023 · External reference
Childhood cancer epidemiology in the Czech Republic (1994–2016)
10.1016/j.canep.2020.101848 · 2020 · External reference
Challenges of cancer registration and epidemiology in Italy
10.1016/j.canep.2025.102804 · 2025 · External reference
Measuring cancer evolution from the genome
10.1002/path.4821 · 2017 · External reference
Use of conditional estimates of effect in cancer epidemiology: An application to lung cancer treatment
10.1016/j.canep.2023.102521 · 2024 · External reference
The future of early cancer detection
10.1038/s41591-022-01746-x · 2022 · External reference
Liquid biopsies: The future of cancer early detection
10.1186/s12967-023-03960-8 · 2023 · External reference
Global cancer patterns: Causes and prevention
10.1016/s0140-6736(13)62224-2 · 2014 · External reference
Effects of nurse-led interventions on early detection of cancer: A systematic review and meta-analysis
10.1016/j.ijnurstu.2020.103684 · 2020 · External reference
Circulating cell-free DNA-based multi-cancer early detection
10.1016/j.trecan.2023.08.010 · 2024 · External reference
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
10.1038/s41571-025-01033-x · 2025 · External reference
Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics
10.1038/s41591-025-03735-2 · 2025 · External reference
Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA
10.1158/2159-8290.cd-23-0456 · 2024 · External reference
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
10.1038/s41568-025-00795-x · 2025 · External reference
10.3390/ijms25158140
10.3390/ijms25158140 · External reference
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging
10.1001/jamainternmed.2025.0505 · 2025 · External reference
10.1016/s0140-6736(12)61611-0
10.1016/s0140-6736(12)61611-0 · External reference
Artificial intelligence-assisted diagnosis of early gastric cancer: Present practice and future prospects
10.1080/07853890.2025.2461679 · 2025 · External reference
The Utility and Limitations of Contrast-Enhanced Ultrasound for the Diagnosis and Treatment of Prostate Cancer
10.3390/s150304947 · 2015 · External reference
Skin Cancer Detection Technology
10.1016/j.det.2019.05.010 · 2019 · External reference
Molecular Skin Cancer Diagnosis: Promise and Limitations
10.1016/j.jmoldx.2022.09.008 · 2023 · External reference
10.1371/journal.pone.0252529
10.1371/journal.pone.0252529 · External reference
Routes to diagnosis of symptomatic cancer in sub-Saharan Africa: Systematic review
10.1136/bmjopen-2020-038605 · 2020 · External reference
Federal Housing Assistance and Stage at Cancer Diagnosis Among Older Adults in the US
10.1001/jamanetworkopen.2025.36281 · 2025 · External reference
Stage at diagnosis for Māori cancer patients: Disparities, similarities and data limitations
2020 · External reference
10.3390/ijms22168661
10.3390/ijms22168661 · External reference
Advances in lung cancer diagnosis and treatment—A review
10.17992/lbl.2022.01.671 · 2022 · External reference
Early diagnosis of oesophageal cancer
2009 · External reference
Breast cancer: New technologies for risk assessment and diagnosis
2003 · External reference
Atomic force microscopy-based cancer diagnosis by detecting cancer-specific biomolecules and cells
10.1016/j.bbcan.2019.03.002 · 2019 · External reference
Exhaled breath and urinary volatile organic compounds (VOCs) for cancer diagnoses, and microbial-related VOC metabolic pathway analysis: A systematic review and meta-analysis
10.1097/js9.0000000000000999 · 2024 · External reference
Extramammary Paget’s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments
10.3390/curroncol28040260 · 2021 · External reference
Molecular Imaging in Cancer Drug Development
10.2967/jnumed.116.188045 · 2018 · External reference
Bone Cancer: Diagnosis and Treatment Principles
2018 · External reference
Imaging bladder cancer
10.1097/mou.0b013e32833cbcb9 · 2010 · External reference
Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine
10.1016/j.mric.2015.08.001 · 2016 · External reference
MRI biomarkers in neuro-oncology
10.1038/s41582-021-00510-y · 2021 · External reference
Low Dose CT for Lung Cancer Screening: The Background, the Guidelines, and a Tailored Approach to Patient Care
2019 · External reference
PET/CT in radiation oncology
10.1053/j.seminoncol.2019.07.001 · 2019 · External reference
Spectral CT imaging: Technical principles of dual-energy CT and multi-energy photon-counting CT
10.1016/j.diii.2022.11.003 · 2023 · External reference
Basis and current state of computed tomography perfusion imaging: A review
10.1088/1361-6560/ac8717 · 2022 · External reference
Photon-counting CT review
10.1016/j.ejmp.2020.10.030 · 2020 · External reference
CT and MR imaging of the thoracic aorta
10.1515/med-2016-0028 · 2016 · External reference
Whole-body MRI in oncology: A comprehensive review
10.1016/j.clinimag.2024.110099 · 2024 · External reference
Molecular Imaging in Oncology Using Positron Emission Tomography
2018 · External reference
PET/MRI evaluation of hepatobiliary tumors
2024 · External reference
PET/MRI in colorectal and anal cancers: An update
10.1007/s00261-023-03897-y · 2023 · External reference
PET/MRI for evaluation of patients with pancreatic cancer
10.1007/s00261-023-03943-9 · 2023 · External reference
Screening for cancer with PET and PET/CT: Potential and limitations
2007 · External reference
Computer-aided diagnosis of prostate cancer with emphasis on ultrasound-based approaches: A review
10.1016/j.ultrasmedbio.2007.01.008 · 2007 · External reference
Clinical applications of ultrasound in neurosurgery and neurocritical care: A narrative review
10.1016/j.mjafi.2023.06.007 · 2024 · External reference
Contrast-enhanced and targeted ultrasound
10.3748/wjg.v17.i1.28 · 2011 · External reference
The design of multifunctional microbubbles for ultrasound image-guided cancer therapy
10.2174/156802610791384180 · 2010 · External reference
Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy
10.1158/0008-5472.can-11-4079 · 2012 · External reference
Epidemiologia oraz diagnostyka raka piersi [Epidemiology and diagnosis of breast cancer]
2019 · External reference
Immunohistochemical and molecular diagnostics tailoring personalised ovarian cancer therapy
10.5114/pjp.2026.162571 · 2026 · External reference
10.3390/biom11111721
10.3390/biom11111721 · External reference
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
10.1016/j.modpat.2022.100084 · 2023 · External reference
Histopathological validation of magnifying endoscopy for diagnosis of mixed-histological-type early gastric cancer
10.3748/wjg.v26.i36.5450 · 2020 · External reference
Deep learning model targeting cancer surrounding tissues for accurate cancer diagnosis based on histopathological images
10.1186/s12967-024-06017-6 · 2025 · External reference
Neural Network Based Classification of Breast Cancer Histopathological Image from Intraoperative Rapid Frozen Sections
10.1007/s10278-023-00802-3 · 2023 · External reference
Standards for prostate biopsy
10.1097/mou.0000000000000031 · 2014 · External reference
Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies
10.3346/jkms.2022.37.e220 · 2022 · External reference
Patient-derived organoids based on targeted biopsy of primary prostate cancer: Development, identification, and drug screening
10.1080/07853890.2025.2602324 · 2025 · External reference
Cancer screening programs in Japan: Progress and challenges
10.1177/09691413241240564 · 2024 · External reference
Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review
10.1016/j.cgh.2019.01.014 · 2019 · External reference
Cervical Cancer Screening: Past, Present, and Future
10.1016/j.sxmr.2019.09.005 · 2020 · External reference
10.1186/s12885-024-12649-0
10.1186/s12885-024-12649-0 · External reference
Liquid biopsy in cancer current: Status, challenges and future prospects
10.1038/s41392-024-02021-w · 2024 · External reference
Liquid biopsy in lung cancer
10.1016/j.cca.2023.117757 · 2024 · External reference
Liquid Biopsy Based on Cell-Free DNA and RNA
10.1146/annurev-bioeng-110222-111259 · 2024 · External reference
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
10.1186/s12943-022-01556-2 · 2022 · External reference
Liquid biopsy in lung cancer
10.1183/20734735.0051-2025 · 2025 · External reference
Liquid Biopsy in Breast Cancer: A Focused Review
10.5858/arpa.2019-0559-ra · 2021 · External reference
Exosomes as a new frontier of cancer liquid biopsy
10.1186/s12943-022-01509-9 · 2022 · External reference
Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence
10.1093/clinchem/hvad176 · 2024 · External reference
Liquid biopsy in ovarian cancer
10.1016/bs.acc.2020.01.001 · 2020 · External reference
10.3390/cells12141916
10.3390/cells12141916 · External reference
Cell-free RNA for the liquid biopsy of gastrointestinal cancer
10.1002/wrna.1791 · 2023 · External reference
Cancer in a drop: Advances in liquid biopsy in 2024
10.1016/j.critrevonc.2025.104776 · 2025 · External reference
Liquid biopsy in lung cancer
10.1093/jjco/hyaf013 · 2025 · External reference
Signaling pathways and therapeutic interventions in gastric cancer
10.1038/s41392-022-01190-w · 2022 · External reference
Molecular features as promising biomarkers in ovarian cancer
10.17219/acem/159799 · 2023 · External reference
Predictive biomarkers in gastric cancer
10.1007/s00432-022-04408-0 · 2023 · External reference
Precursors of urinary bladder cancer: Molecular alterations and biomarkers
10.1016/j.humpath.2022.06.006 · 2023 · External reference
Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer
10.1016/j.ymthe.2020.12.017 · 2021 · External reference
Epigenetic biomarkers in cancer epidemiology
10.1007/978-1-61779-612-8_28 · 2012 · External reference
10.3390/ijms20153842
10.3390/ijms20153842 · External reference
Pan-cancer proteomic map of 949 human cell lines
10.1016/j.ccell.2022.06.010 · 2022 · External reference
Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer
10.1158/0008-5472.can-23-3998 · 2024 · External reference
Metabolomics for Investigating Physiological and Pathophysiological Processes
10.1152/physrev.00035.2018 · 2019 · External reference
High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
10.1038/s41598-021-91276-2 · 2021 · External reference
Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers
10.1016/j.ccell.2024.07.005 · 2024 · External reference
Metabolomic biomarkers discovery across chronic gastritis to gastric cancer progression
10.1038/s41598-025-19005-7 · 2025 · External reference
Salivary metabolomic biomarkers for non-invasive lung cancer detection
10.1111/cas.16112 · 2024 · External reference
10.3390/cancers16142499
10.3390/cancers16142499 · External reference
10.3390/molecules31040650
10.3390/molecules31040650 · External reference
10.1186/s12866-023-03166-4
10.1186/s12866-023-03166-4 · External reference
10.3389/fimmu.2021.807648
10.3389/fimmu.2021.807648 · External reference
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
10.1136/gutjnl-2015-309800 · 2017 · External reference
Measuring gut microbiome as a colorectal cancer screening tool: Potential and challenges
10.1080/17474124.2025.2592078 · 2025 · External reference
Artificial intelligence in diagnostic pathology
10.1186/s13000-023-01375-z · 2023 · External reference
Artificial intelligence in cancer diagnostics and therapy: Current perspectives
10.4103/ijc.ijc_399_20 · 2021 · External reference
Artificial Intelligence-Driven Cancer Diagnostics: Enhancing Radiology and Pathology through Reproducibility, Explainability, and Multimodality
10.1158/0008-5472.can-24-3630 · 2025 · External reference
Radiomics in breast cancer: Current advances and future directions
10.1016/j.xcrm.2024.101719 · 2024 · External reference
Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma
10.1016/j.compbiomed.2024.108337 · 2024 · External reference
Artificial intelligence-based MRI radiomics and radiogenomics in glioma
10.1186/s40644-024-00682-y · 2024 · External reference
Artificial Intelligence-Driven Radiomics in Head and Neck Cancer: Current Status and Future Prospects
10.1016/j.ijmedinf.2024.105464 · 2024 · External reference
Digital pathology and artificial intelligence
10.1016/s1470-2045(19)30154-8 · 2019 · External reference
Artificial intelligence in digital pathology—New tools for diagnosis and precision oncology
10.1038/s41571-019-0252-y · 2019 · External reference
Artificial intelligence entering the pathology arena in oncology: Current applications and future perspectives
10.1016/j.annonc.2025.03.006 · 2025 · External reference
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
10.1016/j.semcancer.2022.12.009 · 2023 · External reference
Artificial intelligence and machine learning in cell-free-DNA-based diagnostics
10.1101/gr.278413.123 · 2025 · External reference
Artificial intelligence for predictive biomarker discovery in immuno-oncology: A systematic review
10.1016/j.annonc.2023.10.125 · 2024 · External reference
Tribulations and future opportunities for artificial intelligence in precision medicine
10.1186/s12967-024-05067-0 · 2024 · External reference
Integrative omics for health and disease
10.1038/nrg.2018.4 · 2018 · External reference
Clinical cancer genomic profiling
10.1038/s41576-021-00338-8 · 2021 · External reference
Single-cell sequencing in cancer research
2021 · External reference
Cancer transcriptome profiling at the juncture of clinical translation
10.1038/nrg.2017.96 · 2018 · External reference
Translating RNA sequencing into clinical diagnostics: Opportunities and challenges
10.1038/nrg.2016.10 · 2016 · External reference
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
10.1056/nejmoa1804710 · 2018 · External reference
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
10.1016/j.cell.2020.06.013 · 2020 · External reference
Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy
10.1016/j.cell.2020.10.036 · 2020 · External reference
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
10.1016/j.cell.2019.03.030 · 2019 · External reference
Systems biology: Metabonomics
10.1038/4551054a · 2008 · External reference
Multi-Omics Factor Analysis—A framework for unsupervised integration of multi-omics data sets
10.15252/msb.20178124 · 2018 · External reference
Artificial intelligence in digital pathology: A systematic review and meta-analysis of diagnostic test accuracy
10.1038/s41746-024-01106-8 · 2024 · External reference
Implementation of digital pathology and artificial intelligence in routine pathology practice
10.1016/j.labinv.2024.102111 · 2024 · External reference
10.3389/fdgth.2024.1358305
10.3389/fdgth.2024.1358305 · External reference
GLIM criteria for the diagnosis of malnutrition: A consensus report from the global clinical nutrition community
10.1016/j.clnu.2018.08.002 · 2019 · External reference
ESPEN practical guideline: Clinical Nutrition in cancer
10.1016/j.clnu.2021.02.005 · 2021 · External reference
Sarcopenia: Revised European consensus on definition and diagnosis
10.1093/ageing/afy169 · 2019 · External reference
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
10.1002/jcsm.13478 · 2024 · External reference
Definition and classification of cancer cachexia: An international consensus
10.1016/s1470-2045(10)70218-7 · 2011 · External reference
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines
10.1016/j.esmoop.2021.100092 · 2021 · External reference
The diagnostic accuracy and cutoff value of phase angle for screening sarcopenia: A systematic review and meta-analysis
10.1016/j.jamda.2024.105283 · 2024 · External reference
Minimal residual disease in solid tumors: An overview
10.1007/s11684-023-1018-6 · 2023 · External reference
Current and future perspectives of liquid biopsies in genomics-driven oncology
10.1038/s41576-018-0071-5 · 2019 · External reference
PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation
10.7326/m18-0850 · 2018 · External reference
Projected Lifetime Cancer Risks From Current Computed Tomography Imaging
10.1001/jamainternmed.2025.0505 · ExternalCitation · doi-reference
Federal Housing Assistance and Stage at Cancer Diagnosis Among Older Adults in the US
10.1001/jamanetworkopen.2025.36281 · ExternalCitation · doi-reference
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
10.1002/jcsm.13478 · ExternalCitation · doi-reference
Measuring cancer evolution from the genome
10.1002/path.4821 · ExternalCitation · doi-reference
Cell-free RNA for the liquid biopsy of gastrointestinal cancer
10.1002/wrna.1791 · ExternalCitation · doi-reference
Epigenetic biomarkers in cancer epidemiology
10.1007/978-1-61779-612-8_28 · ExternalCitation · doi-reference
PET/MRI in colorectal and anal cancers: An update
10.1007/s00261-023-03897-y · ExternalCitation · doi-reference
PET/MRI for evaluation of patients with pancreatic cancer
10.1007/s00261-023-03943-9 · ExternalCitation · doi-reference
Predictive biomarkers in gastric cancer
10.1007/s00432-022-04408-0 · ExternalCitation · doi-reference
Neural Network Based Classification of Breast Cancer Histopathological Image from Intraoperative Rapid Frozen Sections
10.1007/s10278-023-00802-3 · ExternalCitation · doi-reference
Minimal residual disease in solid tumors: An overview
10.1007/s11684-023-1018-6 · ExternalCitation · doi-reference
Liquid biopsy in ovarian cancer
10.1016/bs.acc.2020.01.001 · ExternalCitation · doi-reference
Artificial intelligence for predictive biomarker discovery in immuno-oncology: A systematic review
10.1016/j.annonc.2023.10.125 · ExternalCitation · doi-reference
Artificial intelligence entering the pathology arena in oncology: Current applications and future perspectives
10.1016/j.annonc.2025.03.006 · ExternalCitation · doi-reference
Atomic force microscopy-based cancer diagnosis by detecting cancer-specific biomolecules and cells
10.1016/j.bbcan.2019.03.002 · ExternalCitation · doi-reference
Triple-negative breast cancer: Epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
10.1016/j.bcp.2023.115545 · ExternalCitation · doi-reference
Epidemiology of liver metastases
10.1016/j.canep.2020.101760 · ExternalCitation · doi-reference
Childhood cancer epidemiology in the Czech Republic (1994–2016)
10.1016/j.canep.2020.101848 · ExternalCitation · doi-reference
Use of conditional estimates of effect in cancer epidemiology: An application to lung cancer treatment
10.1016/j.canep.2023.102521 · ExternalCitation · doi-reference
Challenges of cancer registration and epidemiology in Italy
10.1016/j.canep.2025.102804 · ExternalCitation · doi-reference
Liquid biopsy in lung cancer
10.1016/j.cca.2023.117757 · ExternalCitation · doi-reference
Pan-cancer proteomic map of 949 human cell lines
10.1016/j.ccell.2022.06.010 · ExternalCitation · doi-reference
Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers
10.1016/j.ccell.2024.07.005 · ExternalCitation · doi-reference
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
10.1016/j.cell.2019.03.030 · ExternalCitation · doi-reference
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
10.1016/j.cell.2020.06.013 · ExternalCitation · doi-reference
Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy
10.1016/j.cell.2020.10.036 · ExternalCitation · doi-reference
Cost-Effectiveness of Colorectal Cancer Screening Strategies-A Systematic Review
10.1016/j.cgh.2019.01.014 · ExternalCitation · doi-reference
Whole-body MRI in oncology: A comprehensive review
10.1016/j.clinimag.2024.110099 · ExternalCitation · doi-reference
GLIM criteria for the diagnosis of malnutrition: A consensus report from the global clinical nutrition community
10.1016/j.clnu.2018.08.002 · ExternalCitation · doi-reference
ESPEN practical guideline: Clinical Nutrition in cancer
10.1016/j.clnu.2021.02.005 · ExternalCitation · doi-reference
Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma
10.1016/j.compbiomed.2024.108337 · ExternalCitation · doi-reference
Cancer in a drop: Advances in liquid biopsy in 2024
10.1016/j.critrevonc.2025.104776 · ExternalCitation · doi-reference
Skin Cancer Detection Technology
10.1016/j.det.2019.05.010 · ExternalCitation · doi-reference
Spectral CT imaging: Technical principles of dual-energy CT and multi-energy photon-counting CT
10.1016/j.diii.2022.11.003 · ExternalCitation · doi-reference
Photon-counting CT review
10.1016/j.ejmp.2020.10.030 · ExternalCitation · doi-reference
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines
10.1016/j.esmoop.2021.100092 · ExternalCitation · doi-reference
Precursors of urinary bladder cancer: Molecular alterations and biomarkers
10.1016/j.humpath.2022.06.006 · ExternalCitation · doi-reference
Artificial Intelligence-Driven Radiomics in Head and Neck Cancer: Current Status and Future Prospects
10.1016/j.ijmedinf.2024.105464 · ExternalCitation · doi-reference
Effects of nurse-led interventions on early detection of cancer: A systematic review and meta-analysis
10.1016/j.ijnurstu.2020.103684 · ExternalCitation · doi-reference
The diagnostic accuracy and cutoff value of phase angle for screening sarcopenia: A systematic review and meta-analysis
10.1016/j.jamda.2024.105283 · ExternalCitation · doi-reference
Molecular Skin Cancer Diagnosis: Promise and Limitations
10.1016/j.jmoldx.2022.09.008 · ExternalCitation · doi-reference
Implementation of digital pathology and artificial intelligence in routine pathology practice
10.1016/j.labinv.2024.102111 · ExternalCitation · doi-reference
Clinical applications of ultrasound in neurosurgery and neurocritical care: A narrative review
10.1016/j.mjafi.2023.06.007 · ExternalCitation · doi-reference
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
10.1016/j.modpat.2022.100084 · ExternalCitation · doi-reference
Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine
10.1016/j.mric.2015.08.001 · ExternalCitation · doi-reference
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
10.1016/j.semcancer.2022.12.009 · ExternalCitation · doi-reference
Cervical Cancer Screening: Past, Present, and Future
10.1016/j.sxmr.2019.09.005 · ExternalCitation · doi-reference
Circulating cell-free DNA-based multi-cancer early detection
10.1016/j.trecan.2023.08.010 · ExternalCitation · doi-reference
Computer-aided diagnosis of prostate cancer with emphasis on ultrasound-based approaches: A review
10.1016/j.ultrasmedbio.2007.01.008 · ExternalCitation · doi-reference
Radiomics in breast cancer: Current advances and future directions
10.1016/j.xcrm.2024.101719 · ExternalCitation · doi-reference
Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer
10.1016/j.ymthe.2020.12.017 · ExternalCitation · doi-reference
10.1016/s0140-6736(12)61611-0
10.1016/s0140-6736(12)61611-0 · ExternalCitation · doi-reference
Global cancer patterns: Causes and prevention
10.1016/s0140-6736(13)62224-2 · ExternalCitation · doi-reference
Definition and classification of cancer cachexia: An international consensus
10.1016/s1470-2045(10)70218-7 · ExternalCitation · doi-reference
Digital pathology and artificial intelligence
10.1016/s1470-2045(19)30154-8 · ExternalCitation · doi-reference
Systems biology: Metabonomics
10.1038/4551054a · ExternalCitation · doi-reference
Translating RNA sequencing into clinical diagnostics: Opportunities and challenges
10.1038/nrg.2016.10 · ExternalCitation · doi-reference
Cancer transcriptome profiling at the juncture of clinical translation
10.1038/nrg.2017.96 · ExternalCitation · doi-reference
Integrative omics for health and disease
10.1038/nrg.2018.4 · ExternalCitation · doi-reference
Signaling pathways and therapeutic interventions in gastric cancer
10.1038/s41392-022-01190-w · ExternalCitation · doi-reference
Liquid biopsy in cancer current: Status, challenges and future prospects
10.1038/s41392-024-02021-w · ExternalCitation · doi-reference
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
10.1038/s41568-025-00795-x · ExternalCitation · doi-reference
Artificial intelligence in digital pathology—New tools for diagnosis and precision oncology
10.1038/s41571-019-0252-y · ExternalCitation · doi-reference
Promises and pitfalls of multi-cancer early detection using liquid biopsy tests
10.1038/s41571-025-01033-x · ExternalCitation · doi-reference
Current and future perspectives of liquid biopsies in genomics-driven oncology
10.1038/s41576-018-0071-5 · ExternalCitation · doi-reference
Clinical cancer genomic profiling
10.1038/s41576-021-00338-8 · ExternalCitation · doi-reference
MRI biomarkers in neuro-oncology
10.1038/s41582-021-00510-y · ExternalCitation · doi-reference
The future of early cancer detection
10.1038/s41591-022-01746-x · ExternalCitation · doi-reference
Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics
10.1038/s41591-025-03735-2 · ExternalCitation · doi-reference
High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
10.1038/s41598-021-91276-2 · ExternalCitation · doi-reference
Metabolomic biomarkers discovery across chronic gastritis to gastric cancer progression
10.1038/s41598-025-19005-7 · ExternalCitation · doi-reference
Artificial intelligence in digital pathology: A systematic review and meta-analysis of diagnostic test accuracy
10.1038/s41746-024-01106-8 · ExternalCitation · doi-reference
PET/CT in radiation oncology
10.1053/j.seminoncol.2019.07.001 · ExternalCitation · doi-reference
Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer
10.1056/nejmoa1804710 · ExternalCitation · doi-reference
Artificial intelligence-assisted diagnosis of early gastric cancer: Present practice and future prospects
10.1080/07853890.2025.2461679 · ExternalCitation · doi-reference
Patient-derived organoids based on targeted biopsy of primary prostate cancer: Development, identification, and drug screening
10.1080/07853890.2025.2602324 · ExternalCitation · doi-reference
Measuring gut microbiome as a colorectal cancer screening tool: Potential and challenges
10.1080/17474124.2025.2592078 · ExternalCitation · doi-reference
Basis and current state of computed tomography perfusion imaging: A review
10.1088/1361-6560/ac8717 · ExternalCitation · doi-reference
Sarcopenia: Revised European consensus on definition and diagnosis
10.1093/ageing/afy169 · ExternalCitation · doi-reference
Extracellular Vesicles as Liquid Biopsy Biomarkers across the Cancer Journey: From Early Detection to Recurrence
10.1093/clinchem/hvad176 · ExternalCitation · doi-reference
Liquid biopsy in lung cancer
10.1093/jjco/hyaf013 · ExternalCitation · doi-reference
Exhaled breath and urinary volatile organic compounds (VOCs) for cancer diagnoses, and microbial-related VOC metabolic pathway analysis: A systematic review and meta-analysis
10.1097/js9.0000000000000999 · ExternalCitation · doi-reference
Standards for prostate biopsy
10.1097/mou.0000000000000031 · ExternalCitation · doi-reference
Imaging bladder cancer
10.1097/mou.0b013e32833cbcb9 · ExternalCitation · doi-reference
Artificial intelligence and machine learning in cell-free-DNA-based diagnostics
10.1101/gr.278413.123 · ExternalCitation · doi-reference
Salivary metabolomic biomarkers for non-invasive lung cancer detection
10.1111/cas.16112 · ExternalCitation · doi-reference
Routes to diagnosis of symptomatic cancer in sub-Saharan Africa: Systematic review
10.1136/bmjopen-2020-038605 · ExternalCitation · doi-reference
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
10.1136/gutjnl-2015-309800 · ExternalCitation · doi-reference
Liquid Biopsy Based on Cell-Free DNA and RNA
10.1146/annurev-bioeng-110222-111259 · ExternalCitation · doi-reference
Metabolomics for Investigating Physiological and Pathophysiological Processes
10.1152/physrev.00035.2018 · ExternalCitation · doi-reference
Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy
10.1158/0008-5472.can-11-4079 · ExternalCitation · doi-reference
Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer
10.1158/0008-5472.can-23-3998 · ExternalCitation · doi-reference
Artificial Intelligence-Driven Cancer Diagnostics: Enhancing Radiology and Pathology through Reproducibility, Explainability, and Multimodality
10.1158/0008-5472.can-24-3630 · ExternalCitation · doi-reference
Early Cancer Detection in Li-Fraumeni Syndrome with Cell-Free DNA
10.1158/2159-8290.cd-23-0456 · ExternalCitation · doi-reference
Cancer screening programs in Japan: Progress and challenges
10.1177/09691413241240564 · ExternalCitation · doi-reference
Liquid biopsy in lung cancer
10.1183/20734735.0051-2025 · ExternalCitation · doi-reference
10.1186/s12866-023-03166-4
10.1186/s12866-023-03166-4 · ExternalCitation · doi-reference
10.1186/s12885-024-12649-0
10.1186/s12885-024-12649-0 · ExternalCitation · doi-reference
Exosomes as a new frontier of cancer liquid biopsy
10.1186/s12943-022-01509-9 · ExternalCitation · doi-reference
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer
10.1186/s12943-022-01556-2 · ExternalCitation · doi-reference
Liquid biopsies: The future of cancer early detection
10.1186/s12967-023-03960-8 · ExternalCitation · doi-reference
Tribulations and future opportunities for artificial intelligence in precision medicine
10.1186/s12967-024-05067-0 · ExternalCitation · doi-reference
Deep learning model targeting cancer surrounding tissues for accurate cancer diagnosis based on histopathological images
10.1186/s12967-024-06017-6 · ExternalCitation · doi-reference
Artificial intelligence in diagnostic pathology
10.1186/s13000-023-01375-z · ExternalCitation · doi-reference
Artificial intelligence-based MRI radiomics and radiogenomics in glioma
10.1186/s40644-024-00682-y · ExternalCitation · doi-reference
Breast cancer: Presentation, investigation and management
10.12968/hmed.2021.0459 · ExternalCitation · doi-reference
10.1371/journal.pone.0252529
10.1371/journal.pone.0252529 · ExternalCitation · doi-reference
CT and MR imaging of the thoracic aorta
10.1515/med-2016-0028 · ExternalCitation · doi-reference
Multi-Omics Factor Analysis—A framework for unsupervised integration of multi-omics data sets
10.15252/msb.20178124 · ExternalCitation · doi-reference
Molecular features as promising biomarkers in ovarian cancer
10.17219/acem/159799 · ExternalCitation · doi-reference
Advances in lung cancer diagnosis and treatment—A review
10.17992/lbl.2022.01.671 · ExternalCitation · doi-reference
The design of multifunctional microbubbles for ultrasound image-guided cancer therapy
10.2174/156802610791384180 · ExternalCitation · doi-reference
Prostate cancer epidemiology
10.2741/1891 · ExternalCitation · doi-reference
Molecular Imaging in Cancer Drug Development
10.2967/jnumed.116.188045 · ExternalCitation · doi-reference
Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies
10.3346/jkms.2022.37.e220 · ExternalCitation · doi-reference
10.3389/fdgth.2024.1358305
10.3389/fdgth.2024.1358305 · ExternalCitation · doi-reference
10.3389/fimmu.2021.807648
10.3389/fimmu.2021.807648 · ExternalCitation · doi-reference
10.3390/biom11111721
10.3390/biom11111721 · ExternalCitation · doi-reference
10.3390/cancers16142499
10.3390/cancers16142499 · ExternalCitation · doi-reference
10.3390/cells12141916
10.3390/cells12141916 · ExternalCitation · doi-reference
Extramammary Paget’s Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments
10.3390/curroncol28040260 · ExternalCitation · doi-reference
10.3390/ijms20153842
10.3390/ijms20153842 · ExternalCitation · doi-reference
10.3390/ijms22168661
10.3390/ijms22168661 · ExternalCitation · doi-reference
10.3390/ijms25158140
10.3390/ijms25158140 · ExternalCitation · doi-reference
10.3390/molecules31040650
10.3390/molecules31040650 · ExternalCitation · doi-reference
The Utility and Limitations of Contrast-Enhanced Ultrasound for the Diagnosis and Treatment of Prostate Cancer
10.3390/s150304947 · ExternalCitation · doi-reference
Contrast-enhanced and targeted ultrasound
10.3748/wjg.v17.i1.28 · ExternalCitation · doi-reference
Histopathological validation of magnifying endoscopy for diagnosis of mixed-histological-type early gastric cancer
10.3748/wjg.v26.i36.5450 · ExternalCitation · doi-reference
Updates on global epidemiology, risk and prognostic factors of gastric cancer
10.3748/wjg.v29.i16.2452 · ExternalCitation · doi-reference
Artificial intelligence in cancer diagnostics and therapy: Current perspectives
10.4103/ijc.ijc_399_20 · ExternalCitation · doi-reference
Immunohistochemical and molecular diagnostics tailoring personalised ovarian cancer therapy
10.5114/pjp.2026.162571 · ExternalCitation · doi-reference
Liquid Biopsy in Breast Cancer: A Focused Review
10.5858/arpa.2019-0559-ra · ExternalCitation · doi-reference
PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation
10.7326/m18-0850 · ExternalCitation · doi-reference